| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.9M | — | -13.2% |
| Cost of Revenue | $3.0M | — | -14.1% |
| R&D Expense | $4.8M | — | +4.2% |
| SG&A Expense | $19.1M | — | -17.2% |
| Operating Income | -$15.5M | — | +42.4% |
| Pre-tax Income | -$17.1M | — | +35.9% |
| Income Tax | $39K | — | +2.6% |
| Net Income | -$17.1M | — | +35.9% |
| EPS (Basic) | -$1.05 | — | +27.6% |
| EPS (Diluted) | -$1.05 | — | +27.6% |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $254.3M | -6.5% | -12.5% |
| Accounts Receivable | $8.1M | +66.2% | +59.4% |
| Current Assets | $287.5M | -5.2% | -7.8% |
| Total Assets | $359.9M | -3.8% | -5.9% |
| Current Liabilities | $67.7M | +2.8% | +10.1% |
| Long-term Debt | $126.1M |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.9M | — | -148.7% |
| Capital Expenditures | $1.2M | — | +131.5% |
| Investing Cash Flow | -$1.7M | — | -1121.9% |
| Financing Cash Flow | -$4.9M | — | +31.6% |
| Free Cash Flow | -$12.1M | — | -146.9% |
| +1.4% |
| Total Liabilities | $203.1M | +0.9% | +3.2% |
| Stockholders' Equity | $156.8M | -9.4% | -15.5% |